Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -22,906 | N/A | N/A |
| Depreciation Amortization | N/A | N/A | 13,598 | N/A | N/A |
| Accounts receivable | N/A | N/A | 1,238 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 962 | N/A | N/A |
| Other Working Capital | N/A | N/A | 210,863 | N/A | N/A |
| Other Operating Activity | -44,824 | -34,398 | 8,276 | 231,207 | 252,756 |
| Operating Cash Flow | $-44,824 | $-34,398 | $212,031 | $231,207 | $252,756 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -148,449 | -125,213 | -217,178 | -193,771 | -36,305 |
| PPE Investments | -10,215 | -3,141 | -13,665 | -7,050 | -4,209 |
| Purchase Of Investment | -349 | -349 | N/A | N/A | N/A |
| Sale Of Investment | 2,848 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,481 | -210 | -3,402 | -2,585 | -1,253 |
| Other Investing Activity | -1,481 | -210 | -3,402 | -2,585 | -1,253 |
| Investing Cash Flow | $-157,646 | $-128,913 | $-234,245 | $-203,406 | $-41,767 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 12,048 | 5,000 | 5,000 |
| Debt Repayment | -1,166 | -517 | -7,239 | -7,238 | -3,569 |
| Common Stock Issued | 192,627 | 191,143 | 102,776 | 100,505 | 94,686 |
| Other Financing Activity | 2,813 | 2,757 | 0 | 0 | 0 |
| Financing Cash Flow | $194,274 | $193,383 | $107,585 | $98,267 | $96,117 |
| Beginning Cash Position | 223,985 | 223,985 | 138,614 | 138,614 | 138,614 |
| End Cash Position | 215,789 | 254,057 | 223,985 | 264,682 | 445,720 |
| Net Cash Flow | $-8,196 | $30,072 | $85,371 | $126,068 | $307,106 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,824 | -34,398 | 212,031 | 231,207 | 252,756 |
| Capital Expenditure | -10,215 | -3,141 | -13,665 | -7,050 | -4,209 |
| Free Cash Flow | -55,039 | -37,539 | 198,366 | 224,157 | 248,547 |